Breaking News, Collaborations & Alliances

Adva and Autolomous Launch Digital Pioneer Program for Cell Therapy

Will co-lead an early adopter initiative focused on digitizing, decentralizing, and scaling out autologous cell therapy manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

Adva Biotechnology Ltd. and Autolomous Ltd. have joined forces to co-lead the Digital Pioneer Program, an early adopter initiative focused on digitizing, decentralizing, and scaling out autologous cell therapy manufacturing. The program brings together Adva’s automated and closed-system manufacturing platform with Autolomous’ digital orchestration and manufacturing management technologies, forming an integrated solution designed to assure right-first-time production processes are developed wi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters